Search clinical trials for: Neratinib
Total 178 results
-
Puma Biotechnology, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Puma Biotechnology, Inc.Completed
-
Pierre Fabre MedicamentNot yet recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGActive, not recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Withdrawn
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Jules Bordet InstituteWithdrawn
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.CompletedHepatic InsufficiencyRussian Federation
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
Puma Biotechnology, Inc.Completed
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
Bristol-Myers SquibbRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisItaly
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Puma Biotechnology, Inc.CompletedHealthy SubjectsUnited States
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Completed
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, Korea, Republic of, China, United Kingdom, Canada, France, Australia, Denmark, Switzerland, Japan, Malaysia, Italy, Singapore, Taiwan, Belgium, Croatia, Czechia, Romania, Germany, Bahamas, Brazil, Bulgaria, Colombia and more
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
CelgeneActive, not recruiting
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHER2-positive Breast Cancer
-
NSABP Foundation IncWithdrawnColorectal CancerUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
Qilu Pharmaceutical Co., Ltd.UnknownAdvanced Breast CancerChina
-
Guangdong Association of Clinical TrialsRecruitingALK Positive Non-small Cell Lung CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Puma Biotechnology, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, France, Hungary, Poland, Spain
-
SOLTI Breast Cancer Research GroupTerminated
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbRecruitingMDS | Myeloproliferative Neoplasm | Chronic Neutrophilic LeukemiaUnited States
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity IncActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast CancerUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Solid CancerChina
-
Convalife (Shanghai) Co., Ltd.Not yet recruitingHer2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
-
St. Joseph's Hospital and Medical Center, PhoenixNovartis; Wayne State University; Translational Genomics Research InstituteCompletedGlioblastoma | Brain MetastasesUnited States
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors